CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale President and CEO sold 19,500 shares at $10.82 ($210,908)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,175 shares at $7.79 ($24,718)
- 4 Open-market buy Director bought 20,000 shares at $7.89 ($157,800)
- 4 Open-market buy Director bought 5,000 shares at $9.17 ($45,825)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Legal & Compliance sold 24,000 shares at $9.21 ($221,004)
- 144 Insider Sale of Securities
- 4 Option exercise Chief Legal & Compliance acquired 66,666 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 44 · 870 filings